myofascial pain syndrome
Conditions
Interventions
Press needle placement is performed on patients with advanced cancer who are hospitalized in our palliative care ward and have myofascial pain syndrome. On day 0, the pain site that meets the diagnost
s diagnostic criteria. On day 1, a 1.5 mm press needle is placed.
Sponsors
NHO Hokkaido Cancer Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Eastern Cooperative Oncology Group Performance Status (ECOG-PS) 2-4 2)Those diagnosed with MPS who meet River's diagnostic criteria 3)Those with pain in the area affected by MPS of NRS 4/10 4)Those whose MPS is caused by being bedridden for more than one week
Exclusion criteria
Exclusion criteria: 1)Those who are likely to bleed easily 2)Those who are likely to be susceptible to infection 3)Those who have skin abnormalities such as redness, swelling, or edema at the site of pain that may be MPS
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Difference in pain change 24 hours before and after placement of press needles (Numerical Rating Scale) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Secondary effects other than pain relief (improvement of sleep, fatigue, etc.) 2) Frequency of adverse events | — |
Countries
Japan
Contacts
Public ContactKenji Yamamoto
NHO Hokkaido Cancer Center Division of Palliative Care Medicine
Outcome results
None listed